3M Beats Q2 Estimates, Raises Guidance; Execs Cash Out

NEW YORK, July 25 —

3M Company delivered Q2 2026 EPS of $2.14 against a $1.98 consensus estimate, its third consecutive quarterly beat, and raised its full-year guidance. The stock jumped 9% on July 21, per Quiver Quantitative. Within 48 hours, four C-suite executives had filed Form 4s covering $3.65 million in open-market share sales at the elevated price.

Three for Three

Three straight earnings beats point either to rebuilt operational discipline or carefully managed expectation-setting. At 3M, the run looks like the former. Q4 2025 delivered $2.19 against a $2.07 estimate. Q1 2026 came in at $1.83 against $1.80. Q2 2026: $2.14 against $1.98, with a full-year guidance upgrade accompanying the print, per Barron's.

The financial foundation backs the narrative. Trailing 12-month free cash flow is $6.35 billion on $25.18 billion in revenue — a cash conversion rate that most industrial conglomerates would not complain about. Gross margin is 39.4%. Revenue growth at 2.5% year-over-year is modest, but 3M's appeal has never been growth; it is durable cash generation from a diversified industrial franchise. At 17.9x forward earnings, a $172.62 share price, and a $89 billion market cap, the consensus analyst target of $180.38 implies roughly 4.5% additional upside from current levels — a narrow gap suggesting the market has absorbed most of the good news.

The 48-Hour Window

The sequence after the earnings print is precise and documented. On July 22, EVP and Chief Legal Officer Kevin H. Rhodes sold 7,669 shares at $171.20, realizing $1.31 million. Group President Christian Goralski sold 4,902 shares at $170.46 for $835,577. On July 23, EVP John Patrick Banovetz sold 7,880 shares at $170.44 for $1.34 million. Sr. VP and CAO Theresa Reinseth sold 924 shares at $169.42 for $156,544.

Four executives. $3.65 million combined. Every sale at prices that existed only because of the earnings-day surge. None of this is evidence of wrongdoing — insiders sell for personal financial reasons disconnected from their company outlook all the time. What distinguishes this pattern is the concentration: four senior officers acting in the same 48-hour window, at the post-earnings high. Taken together, that is a less ambiguous signal than any single seller would send.

Exercise and Exit

For Banovetz, Rhodes, and Goralski, the Form 4 filings show the mechanism clearly: each exercised stock options at a strike price of $154.69 per share on the same day as the open-market sale. With shares trading at $170–$171, the spread was approximately $16 per share. Exercising and immediately selling locks in that gain while avoiding the risk of holding freshly acquired shares through any post-earnings give-back.

This is a standard and legal form of equity compensation. The timing stands out: the options were exercised at the precise moment when the post-earnings pop had stretched the spread to its highest recent level. Management delivered the beat and guidance upgrade; the market repriced the stock; the people closest to the business cashed out at the top of the move. That sequence is entirely legal and rational from an executive standpoint. Whether it signals management's view of fair value is a question investors can reasonably ask.

When Q3 Settles It

The bull case for 3M has real substance: three consecutive beats, an upward guidance revision, $6.35 billion in trailing free cash flow, and a 17.9x forward multiple that is not demanding for a business with those cash characteristics. The clean print is not in dispute.

The complication is that the executives with the best visibility into 3M's operations chose, as a group, to cut their exposure on the first available trading day after the earnings release. That does not invalidate the bull case, but it limits the confidence with which an outside investor can lean into the optimistic guidance scenario. Planned option exercises have an element of pre-commitment — these transactions may have been scheduled well in advance of the earnings outcome. Even granting that, the aggregate $3.65 million in sales at the post-earnings high adds a note of caution that the earnings print alone would not.

Q3 earnings become the referendum. Revenue growth at 2.5% is compatible with the current multiple if margins hold and free cash flow continues at this pace; it becomes a harder story to defend if topline momentum stalls while the insider monetization pattern continues. The next data point will show whether the guidance upgrade represents real acceleration or a carefully calibrated baseline designed to be cleared. Run the free 3M Company deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What did 3M report in Q2 2026 earnings?

3M Company reported Q2 2026 EPS of $2.14 against a consensus estimate of $1.98, beating expectations by roughly 8%. The company also raised its full-year guidance alongside the earnings release, per Barron's, marking the third consecutive quarter of beating estimates.

Why did MMM stock rise 9% in July 2026?

MMM stock rose 9% on July 21, 2026, in direct response to 3M's Q2 earnings beat and full-year guidance upgrade. The move reflected both the magnitude of the EPS surprise — $2.14 actual versus $1.98 consensus — and investor confidence in a third straight quarterly beat.

Did 3M insiders sell stock after Q2 2026 earnings?

Four 3M executives sold a combined $3.65 million in shares on July 22–23, 2026, within 48 hours of the post-earnings price surge. The sellers included EVPs John Patrick Banovetz and Kevin H. Rhodes, Group President Christian Goralski, and Sr. VP and CAO Theresa Reinseth, per SEC Form 4 filings.

What is 3M's stock price target for 2026?

As of July 25, 2026, the consensus analyst price target for MMM is $180.38, against a current share price of $172.62, implying roughly 4.5% upside. The stock trades at 17.9x forward earnings with a market capitalization of $89 billion.

Is MMM stock a buy after Q2 2026 earnings?

The earnings picture is constructive — three consecutive beats, a guidance raise, and $6.35 billion in trailing free cash flow — but four executives sold a combined $3.65 million in stock within 48 hours of the 9% post-earnings surge, which warrants caution. The neutral case holds until Q3 results clarify whether the guidance upgrade reflects genuine revenue acceleration or conservative baseline management.